Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Balchem (BCPC)

Balchem Q3 2024 net sales rise 4.3% to $239.9 million; GAAP EPS $1.03 vs $0.90

Positive Impact 3 of 5 earnings Written later

Balchem reported third quarter 2024 results for the period ended September 30, 2024, with net sales up 4.3% to $239.9 million and GAAP net earnings up 16.4% to $33.8 million. Adjusted EBITDA rose 7.6% to $64.4 million, and the company reported $1.2 million...

Key points

  • Net sales were $239.9 million, up 4.3% from $229.9 million in the prior year quarter.
  • GAAP diluted earnings per share were $1.03, compared with $0.90 a year earlier; adjusted earnings per share were $1.13, compared with $1.04.
  • Adjusted EBITDA was $64.4 million, up 7.6%, and free cash flow was $42.2 million.
  • Net debt was $153.3 million after $39.6 million of revolving debt repayments, a net leverage ratio of 0.6 times.

The filing

CompanyBalchem (BCPC)
Form8-K, current report
Filed with the SECOct 25, 2024, 7:42 AM ET
Accession number0001628280-24-043760

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 25, 2024.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.